COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,363 Articles (22,803 medRxiv, 8,560 bioRxiv)

Most recent first Previous |  Page 2077: Articles 20761-20770  | Next

Assessment of the Impacts of Pharmaceutical and Non-pharmaceutical Intervention on COVID-19 in South Africa Using Mathematical Model
Musa, R., Ezugwu, A. E., Mbah, G. C.
10.1101/2020.11.13.20231159 — Posted: 2020-11-16
Clinico-pathological features in fatal Covid-19 Infection: A Preliminary Experience of a Tertiary Care Centre in North India using Post-Mortem Minimally Invasive Tissue Biopsies
Ray, A., Jain, D., Agarwal, S., Swaroop, S., Goel, A., Das, P., Arava, S. K., Mridha, A. R., Nambirajan, A., Singh, G., Arulselvi, S., Mathur, P., Kumar, S., Sahni, S., Nehra, J., Nazneen, , BM, M., Rastogi, N., Mahato, S., Gupta, C., Bharadhan, S., Dhital, G., Goel, P., Pandey, P., KN, S., Chaudhary, S., Keri, V. C., Chauhan, V. S., Mahishi, N., Shahi, A., R, R., Gupta, B., Aggarwal, R., Soni, K. D., Nischal, N., Soneja, M., Lalwani, S., Sarkar, C., Guleria, R., Wig, N., Trikha, A.
10.1101/2020.11.12.20229658 — Posted: 2020-11-16
Continued Age Shift of Confirmed Positive COVID-19 Incidence Over Time to Children and Young Adults: Washington State March - August 2020
Malmgren, J., Guo, B., Kaplan, H.
10.1101/2020.11.12.20229468 — Posted: 2020-11-16
Sex differences in the decline of neutralizing antibodies to SARS-CoV-2
Grzelak, L., Velay, A., Madec, Y., Gallais, F., Staropoli, I., Schmidt-Mutter, C., Wendling, M.-J., Meyer, N., Planchais, C., Rey, D., Mouquet, H., Glady, L., Hansmann, Y., Bruel, T., De Seze, J., Fontanet, A., Gonzalez, M., Schwartz, O., Fafi-Kremer, S.
10.1101/2020.11.12.20230466 — Posted: 2020-11-15 Discussion: Onsite
Correlation of Body Mass Index (BMI), initial neutralizing antibodies (nAb), ABO group and kinetics of nAb and anti-nucleocapsid (NP) SARS-CoV-2 antibodies in convalescent plasma (CCP) donors: A longitudinal study with proposals for better quality of CCP collections.
Wendel, S., Fontao-Wendel, R., Fachini, R. M., Candelaria, G., Scuracchio, P., Achkar, R., Brito, M. A., Reis, L. F. L., Camargo, A., Amano, M. T., Machado, R. R., Araujo, D., Soares, C. B., Durigon, E.
10.1101/2020.11.12.20230391 — Posted: 2020-11-15
Protective behaviours and secondary harms from non-pharmaceutical interventions during the COVID-19 epidemic in South Africa: a multisite prospective longitudinal study
Harling, G., Gomez-Olive, F. X., Tlouyamma, J., Mutevedzi, T., Kabudula, C. W., Mahlako, R., Singh, U., Ohene-Kwofie, D., Buckland, R., Ndagurwa, P., Gareta, D., Gunda, R., Mngomezulu, T., Nxumalo, S., Wong, E. B., Kahn, K., Siedner, M. J., Maimela, E., Tollman, S., Collinson, M., Herbst, K.
10.1101/2020.11.12.20230136 — Posted: 2020-11-15
Mobile consulting (mConsulting) as an option for accessing healthcare services for communities in remote rural areas and urban slums in low- and middle- income countries: A mixed methods study
Harris, B., Ajisola, M., Alam, R., Antsley Watkins, J., Arvanitis, T. N., Bakibinga, P., Chipwaza, B., Choudhury, N. N., Fayhun, O., Kibe, P., Omigbodun, A., Owoaje, E., Pemba, S., Potter, R., Rizvi, N., Sturt, J., Cave, J. A. K., Iqbal, R., Kabaria, C., Kalolo, A., Kyobutungi, C., Lilford, R. J., Mashanya, T., Ndegese, S., Rahman, O., Sayani, S., Yusuf, R., Griffiths, F.
10.1101/2020.11.12.20229955 — Posted: 2020-11-15
COVID-19 COGNITIVE DEFICITS AFTER RESPIRATORY ASSISTANCE IN THE SUBACUTE PHASE:A COVID-REHABILITATION UNIT EXPERIENCE
Alemanno, F., Houdayer, E., Parma, A., Spina, A., Del Forno, A., Scatolini, A., Angelone, S., Brugliera, L., Tettamanti, A., Beretta, L., Iannaccone, S.
10.1101/2020.11.12.20229823 — Posted: 2020-11-15
SARS-CoV-2: Proof of recombination between strains and emergence of possibly more virulent ones
Haddad, D., John, S. E., Mohammad, A., Hammad, M. M., Hebbar, P., Channanath, A., Nizam, R., Al-Qabandi, S., Al Madhoun, A., Alshukry, A., Ali, H., Thanaraj, T. A., Al-Mulla, F.
10.1101/2020.11.11.20229765 — Posted: 2020-11-15
Asymptomatic and symptomatic SARS-CoV-2 infections elicit polyfunctional antibodies.
Dufloo, J., Grzelak, L., Staropoli, I., Madec, Y., Tondeur, L., Anna, F., Pelleau, S., Wiedemann, A., Planchais, C., Buchrieser, J., Robinot, R., Ungeheuer, M.-N., Mouquet, H., Charneau, P., White, M., Levy, Y., Hoen, B., Fontanet, A., Schwartz, O., Bruel, T.
10.1101/2020.11.12.20230508 — Posted: 2020-11-15

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).